The prognostic value of health-related quality-of-life data in predicting survival in glioblastoma cancer patients: results from an international randomised phase III EORTC Brain Tumour and Radiation Oncology Groups, and NCIC Clinical Trials Group study

This is one of the few studies that have explored the value of baseline symptoms and health-related quality of life (HRQOL) in predicting survival in brain cancer patients. Baseline HRQOL scores (from the EORTC QLQ-C30 and the Brain Cancer Module (BN 20)) were examined in 490 newly diagnosed gliobla...

Descripción completa

Detalles Bibliográficos
Autores principales: Mauer, M, Stupp, R, Taphoorn, M J B, Coens, C, Osoba, D, Marosi, C, Wong, R, de Witte, O, Cairncross, J G, Efficace, F, Mirimanoff, R O, Forsyth, P, van den Bent, M J, Weller, M, Bottomley, A
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2007
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2360328/
https://www.ncbi.nlm.nih.gov/pubmed/17609661
http://dx.doi.org/10.1038/sj.bjc.6603876

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2360328/
https://www.ncbi.nlm.nih.gov/pubmed/17609661
http://dx.doi.org/10.1038/sj.bjc.6603876

Ejemplares similares